Cano Health Inc. (NYSE:CANO) saw a downside of -7.33% to close Friday at $11.26 after subtracting -$0.89 on the day. The 5-day average trading volume is 3,157,880 shares of the company’s common stock. It has gained $13.22 in the past week. An average of 4,451,635 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,336,602.
CANO’s 1-month performance is -14.37% or -$1.62 on its low of $10.87 reached on 10/08/21. The company’s shares have touched a 52-week low of $9.20 and high of $17.43, with the stock’s rally to the 52-week high happening on 01/06/21. YTD, CANO has lost -16.03% or -$2.15. However, the current price is down -35.40%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Cano Health Inc. (CANO) has a trailing price-to-earnings (P/E) ratio of 23.70 for the broader industry and 31.93 for the sector.CANO stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 14.83 while the price-to-book (PB) in the most recent quarter is 1.75.
Cano Health Inc.’s quick ratio for the period ended June 29 was 0.20, with the current ratio over the same period at 0.20 meaning that CANO stock is not able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00 while for the period ending June 29; Cano Health Inc.’s operating margin was -7.30%.
For the quarterly period ending June 29 this year, Analysts expected CANO to announce -$0.01 per share in earnings in its latest quarter, but it posted $0.01, representing a 200.00% surprise. EBITDA for the quarter stood at more than -$13.33 million. CANO stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 770.86 million, with total debt at $535.18 million. Shareholders hold equity totaling $479.99 million
Let’s look briefly at Cano Health Inc. (CANO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 October was 24.66% to suggest the stock is trending oversold, with historical volatility in this time period at 50.92%.
The stock’s 5-day moving average is $12.23, reflecting a -15.02% or -$1.99 change from its current price. CANO is currently trading -19.57% above its 20-day SMA, -15.15% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +5.04% and -19.28% respectively.
Stochastic %K and %D was 6.75% and 9.44% and the average true range (ATR) pointed at 0.91. The RSI (14) points at 33.89%, while the 14-day stochastic is at 9.18% with the period’s ATR at 0.91. The stock’s 9-day MACD Oscillator is pointing at -0.65 and -1.24 on the 14-day charts.
In the most recent analyst report for Cano Health Inc. (NYSE: CANO), Wolfe Research launched coverage with an Outperform rating. Analysts offering their rating for CANO stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate CANO as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is CANO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $18.00 and a high of $22.00, with their median price target at $19.00. Looking at these predictions, the average price target given by analysts is for Cano Health Inc. (CANO) stock is $19.40.